Navigation Links
Genomatix Microarray Analysis Pipeline achieves Affymetrix GeneChip compatible?status

Genomatix Software GmbH today announced that it has achieved GeneChip-compatibleTM status for several products with the Affymetrix Inc.

GeneChip® microarray platform and that it has joined Affymetrix GeneChip-compatible Applications Program, which provides customers with a broad spectrum of software solutions for biomedical research and development. As a GeneChip-compatible software provider, Genomatix is committed to seamlessly integrating its entire microarray analysis pipeline with the Affymetrix technology.

The Genomatix line of products which achieved GeneChip-compatibleTM status consists of ChipInspector, ChipInspector TL, ElDorado, GEMS Launcher, and BiblioSphere PathwayEdition. With those products Genomatix provides a broad set of solutions for Affymetrix GeneChip users, including analysis of data from Affymetrix whole-genome tiling and exon arrays.

"We are proud of having met the high standards of Affymetrix and earning GeneChip-compatibleTM status. The tight integration of our microarray analysis pipeline with the Affymetrix platform will stimulate exciting new results in both basic and applied biomedical R&D," said Klaus May, Director of Sales and Marketing at Genomatix. "Especially in conjunction with the new Affymetrix tiling and exon array technology, I expect that our tools will drive far greater understanding of genomic organization and transcriptome regulation."

"Affymetrix is pleased to be working with Genomatix in their efforts to develop advanced tools for analyzing GeneChip data," said Steve Lincoln, vice president of Informatics at Affymetrix. "We are particularly excited to see the emergence of next-generation commercial software which can help bring unprecedented levels of genomic resolution into the hands of applied biomedical researchers."


'"/>

Source:Genomatix Software GmbH


Page: 1

Related biology news :

1. Genomatix, AAAS ink agreement
2. Genomatix technology facilitates de novo identification of new renal disease associated genes
3. MatBase -- A new transcription factor knowledge base released by Genomatix
4. Application of Genomatix in silico methods reveals novel cancer associated genes
5. Affymetrix Unveils Plans to Double Plant and Animal Genome Microarray Offering
6. Study Demonstrates Gene Expression Microarrays are Comparable and Reproducible
7. Breakthrough Microarray-based Technology for the Study of Cancer
8. Nanogen Issued Patent for Electronic Microarray With Memory
9. Characterizing Skin Cancer by Microarrays
10. Microarrays as phenotype
11. $6.5 Million Grant for Microarray Center at Yale School of Medicine

Post Your Comments:
(Date:11/24/2009)... long held secrets of the earth,s history locked i...en very little information on the environments tha...ns of years. Now, a team of researchers from nine ...he tune of $10 million dollars by the National Sci...hings literally. These scientists will drill thro...
(Date:11/24/2009)...2009) New research on bacterial communities throu...edictable temporal patterns, suggesting that scien...onitoring climate change in the polar regions. The... the National Academy of Sciences Early Edition, ... shifted synchronously over time, correlating with...
(Date:11/23/2009)...ts strong evidence that the "synergistic" effect o...ted pollution and indoor endotoxin causes more har...re alone. , Environmental health scientists at...cine have shown that children exposed to both high...dotoxin during early life are six times more likel...
Breaking Biology News(10 mins):LSU gets to the bottom of things -- in Antarctica 2Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Sorrento Therapeutics Inc and QuikByte Software Inc Complete Merger 14153 1Sorrento Therapeutics Inc and QuikByte Software Inc Complete Merger 14153 2Sorrento Therapeutics Inc and QuikByte Software Inc Complete Merger 14153 3Sorrento Therapeutics Inc and QuikByte Software Inc Complete Merger 14153 4NxStage Patient Takes Dialysis Machine on Third Annual Patient Good Will Tour 57690 1NxStage Patient Takes Dialysis Machine on Third Annual Patient Good Will Tour 57690 2NxStage Patient Takes Dialysis Machine on Third Annual Patient Good Will Tour 57690 3Sunesis Pharmaceuticals Receives NASDAQ Notification 14152 1Sunesis Pharmaceuticals Receives NASDAQ Notification 14152 2Sunesis Pharmaceuticals Receives NASDAQ Notification 14152 3
...One of the great scientific challenges is to under...an brain. New research has shed light on the evolu...to the remarkably complex structure found in human...one that gives more brain power, but that, during ...ocessing of nerve impulses allowed development of ...
... How will the only male rhea at the Smithsonian,s ...much like he has spent the past eight weeks: as a ...s born April 20. This is the first time in some 30... "The birth of these chicks comes at a time when ...o biologist Sara Hallager. "By developing a rhea s...
...ANN ARBOR, Mich.---Developing fundamental math and...evelopment, cellular migration and growth could op...chers say. , A group of these scientists and engi...for the Symposium on Cellular, Molecular and Tissu... the organization of this event. , Symposium part...
Other Biology News:Origins of the brain 2Origins of the brain 3Forum to focus on math and mechanics behind life processes 2Forum to focus on math and mechanics behind life processes 3
(Date:11/24/2009)...anghaiBiolaxyannouncedthe,ChineseStateFood&Dru...lnewdrugapplication(IND)foritsoralinsulinproject,(...tes.ThisIND,approvalallowsBiolaxytoinitiateitsfirs...aracteristicofhighbloodglucoseandpoor,metabolism.T...and,macro-vasculardiseases,lossofvision,kidneyfail...
(Date:11/24/2009).../PRNewswire-FirstCall/-HamiltonThorneLtd.(TSX-V:HT...vancedlasersystemsandinstrumentsforthestemcellrese...onalandfinancialresultsforthethirdquarterendedSept...46millioncomparedwith$1.43millioninQ32008,-Grosspr...3,2008,-Netlossreducedto$148,000comparedto$283,000...
(Date:11/24/2009)...HealthRoboticstodayannounced,thatithasformedanewCa...hisrecentlyformedToronto-basedcompanywilloperateun...install,andsupport,HealthRobotics,i.v.RoomoftheFut...feringsi.v.STATION(TM),i.v.SOFT(TM),andOMM(TM).,He...n"asneeded,basis"toitsstrategicpartnershipswithMcK...
(Date:11/23/2009)...cative new study, a University of Utah scientist a...jor cause of global warming cannot be stabilized ...ilds the equivalent of one new nuclear power plant... be any substantial near-term departure from recen...on rates," says the new paper by Tim Garrett, an a...
Breaking Biology Technology:Biolaxy Secures IND Approval for Oral Insulin 2Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2Is global warming unstoppable? 2Is global warming unstoppable? 3Is global warming unstoppable? 4
...VEX 1-41 has significant neuroprotec...PRNewswire-FirstCall/ - Anavex Life Sciences Corp....romising developments with,ANAVEX 1-41, the compan...n,recent pre-clinical animal studies, ANAVEX 1-41 ...oys cells and is believed to be a primary cause of...
...Standards and Technology (NIST) have a mechanical ...ted values for other nanoscale devices such as car...l quartz crystals. Because a high Q factor indicat... might be used as oscillators in nano-electromecha...ations devices. , We think the most interesting t...
..., Inc.,a privately-held transdermal drug delivery ...s Gardner, M.D. and Daniel G. Welch to the Board o...sex Woodlands Health,Ventures, is a Professor of M...d in the fields of cell biology and pharmacology. ...been active in the biotechnology and,pharmaceutica...
Other Biology Technology:Anavex advances drug candidate for treatment of Alzheimer's disease 2Anavex advances drug candidate for treatment of Alzheimer's disease 3Anavex advances drug candidate for treatment of Alzheimer's disease 4Anavex advances drug candidate for treatment of Alzheimer's disease 5'High Q' NIST nanowires may be practical oscillators 2Corium International, Inc. Announces Appointment of Phyllis Gardner, M.D. and Daniel G. Welch to Board 2Corium International, Inc. Announces Appointment of Phyllis Gardner, M.D. and Daniel G. Welch to Board 3
Chicken Anti-TXNL2 Polyclonal Antibody, Unconjugated from ProSci, Inc
Goat Anti-Bacillus species Glucose Dehydrogenase Polyclonal Antibody, Unconjugated from Abcam
Goat Anti-Human HNF4 Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-ATGL Polyclonal Antibody, Unconjugated from Cell Signaling Technology
Biology Products: